Mainstream

The9 backed nanyang biologics to go public via $1.5b spac merger; shares up

The9-backed Nanyang Biologics to go public via $1.5B SPAC merger; shares up

The9-backed Nanyang Biologics to go public via $1.5B SPAC merger; shares up

Post Contentncty, rfaiRead More

You might also be interested in reading Markets Face Bumpy Climb After Peak Tariff Uncertainty, Nansen Says.

October 2, 2025
In Mainstream